NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
27/10/2023
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
BIOINVENT
ST13
US500000076019918Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Nancy DiConza FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
proteins for scientific and research use; [ chemical preparations for use in protein analysis; ] [ chemicals and chemical preparations for use in the manufacture of pharmaceuticals; proteins for immunoassay for detection of cancer, ] [ autoimmune disease, infection, ] [ cardiovascular disease, ] [ liver dysfunction, kidney dysfunction, ] [ inflammatory disease; ] [ and for toxicological studies for scientific use; proteins for biotechnological purposes, namely, chromatography; ] [ binding proteins and immunoassay reagents contained in boxes, trays or other receptacles, sold together as a unit, for scientific use ]
Classe 5
[ diagnostic proteins for clinical or medical laboratory analysis; ] proteins for therapeutic use for treating cancer, [ autoimmune disease, infection, ] cardiovascular disease, [ liver dysfunction, kidney dysfunction, toxicological conditions ] and inflammatory disease; biopharmaceuticals for use in cancer, [ autoimmune disease, infection, ] cardiovascular disease, [ liver dysfunction, kidney dysfunction, ] inflammatory disease; [ and toxicological conditions; ] [ laboratory testing kits for clinical or medical purposes comprising a box, tray or other receptacle holding vials containing binding proteins and immunoassays reagents, sold together as a unit ]
Classe 9
[ laboratory testing kits for research purposes comprising a box, tray or other receptacle holding vials containing binding proteins and immunoassay reagents, sold together as a unit ]
Classe 40
Contract manufacturing of antibodies for third parties
Classe 42
Scientific research and pharmaceutical drug development services, for others
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
27/10/2023
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
27/10/2023
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27/10/2023
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/10/2023
TEAS SECTION 8 & 9 RECEIVED
02/05/2023
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/11/2021
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/11/2020
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/11/2020
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/11/2020
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/11/2020
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/11/2020
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/11/2020
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
05/04/2017
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/01/2017
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
26/01/2013
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
26/01/2013
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
26/01/2013
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/01/2013
TEAS SECTION 8 & 9 RECEIVED
10/01/2013
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/05/2009
ASSIGNED TO PARALEGAL
01/05/2009
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
29/04/2009
TEAS SECTION 8 & 15 RECEIVED
29/04/2009
CASE FILE IN TICRS
18/12/2007
REGISTERED-PRINCIPAL REGISTER
05/11/2002
PUBLISHED FOR OPPOSITION
13/08/2002
NOTICE OF PUBLICATION
24/07/2002
APPROVED FOR PUB - PRINCIPAL REGISTER
13/05/2002
ASSIGNED TO EXAMINER
13/05/2002
ASSIGNED TO EXAMINER
23/04/2002
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2002
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/12/2001
FINAL REFUSAL MAILED
18/12/2001
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/04/2001
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2001
NON-FINAL ACTION MAILED
13/09/2000
ASSIGNED TO EXAMINER
11/09/2000
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.